Trial intelligence / Profile preview

Preoperative intravenous ondansetron before spinal anesthesia for cesarean section

IRCT20190327043122N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial of ondansetron (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Maximum sensory block level, Time to regression of sensory block to S1 and 1 more. Started Nov 2019; status: completed.

02

Drugs

ondansetron

Beyond the preview

Go deeper on IRCT20190327043122N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190327043122N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call